Pair Name | Plumbagin, Celecoxib | ||
Phytochemical Name | Plumbagin (PubChem CID: 10205 ) | ||
Anticancer drug Name | Celecoxib (PubChem CID: 2662 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Plumbagin, Celecoxib | |||
Disease Info | [ICD-11: 2C30] | Melanoma | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Expression | COX2 | hsa4513 |
Down-regulation | Expression | STAT3 | hsa6774 | |
In Vitro Model | UACC-903 | Cutaneous melanoma | Homo sapiens (Human) | CVCL_4052 |
Mel JuSo | Cutaneous melanoma | Homo sapiens (Human) | CVCL_1403 | |
A375-M | Amelanotic melanoma | Homo sapiens (Human) | CVCL_B222 | |
1205Lu | Cutaneous melanoma | Homo sapiens (Human) | CVCL_5239 | |
In Vivo Model | Subcutaneous injection of 1.0×10⁶ UACC 903 or 1205 Lu melanoma cells were injected above both the left and right rib cages of 4-5 week-old female Athymic-Foxn1nu nude mice | |||
Result | Combination of Celecoxib and Plumbagin decreased melanoma cell proliferation and retarded vascular development of tumors mediated by inhibition of COX-2 and STAT3 leading to decreased levels of key cyclins key on which melanoma cell were dependent for survival. |
No. | Title | Href |
---|---|---|
1 | Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth. Cancer Lett. 2017 Jan 28;385:243-250. doi: 10.1016/j.canlet.2016.10.016. | Click |